Eli Lilly invests in startup Abridge for clinical trial recruitment - Endpoints News
Abridge started as an ambient scribe that uses AI to record and transcribe conversations between patients and doctors during appointments. It has ...
Read the original at Endpoints News ↗
- Topics
- Healthcare
- Tracked via
- “that uses AI to”